284 related articles for article (PubMed ID: 6542166)
21. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
[TBL] [Abstract][Full Text] [Related]
22. [treatment of an epistaxis using a bilateral nasolabial flap in Osler-Rendu disease].
Benassayag C; Boudard P; Portmann D
Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):305-7. PubMed ID: 8638056
[TBL] [Abstract][Full Text] [Related]
23. Combined therapy for epistaxis by hereditary hemorrhagic teleangiectasia: A 3-year follow up study on 45 patients.
Papaspyrou G; Hecker D; Linxweiler M; Schick B; Al Kadah B
J Craniomaxillofac Surg; 2017 Aug; 45(8):1179-1182. PubMed ID: 28615135
[TBL] [Abstract][Full Text] [Related]
24. Using the KTP/532 laser to control epistaxis in patients with hereditary hemorrhagic telangiectasia.
Vickery CL; Kuhn FA
South Med J; 1996 Jan; 89(1):78-80. PubMed ID: 8545698
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
26. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
Joshi H; Woodworth BA; Carney AS
J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
[TBL] [Abstract][Full Text] [Related]
27. Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
Levine CG; Ross DA; Henderson KJ; Leder SB; White RI
Otolaryngol Head Neck Surg; 2008 Jun; 138(6):721-4. PubMed ID: 18503842
[TBL] [Abstract][Full Text] [Related]
28. Non-contact applications of Nd:YAG laser in nasal surgery.
Dobrovic M; Hosch H
Rhinology; 1994 Jun; 32(2):71-3. PubMed ID: 7939144
[TBL] [Abstract][Full Text] [Related]
29. [Intractable epistaxis in Osler-Rendu-Weber syndrome].
Zalagh M; Errami N; Bouaity B; Hemmaoui B; Itoua W; Benariba F
Rev Stomatol Chir Maxillofac; 2011 Nov; 112(5):310-2. PubMed ID: 21940027
[TBL] [Abstract][Full Text] [Related]
30. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.
Siegel MB; Keane WM; Atkins JF; Rosen MR
Otolaryngol Head Neck Surg; 1991 Nov; 105(5):675-9. PubMed ID: 1754250
[TBL] [Abstract][Full Text] [Related]
31. Clinical strategy in hereditary hemorrhagic telangiectasia.
Kühnel TS; Wagner BH; Schurr CP; Strutz J
Am J Rhinol; 2005; 19(5):508-13. PubMed ID: 16270607
[TBL] [Abstract][Full Text] [Related]
32. External beam radiotherapy for severe epistaxis from Osler-Weber-Rendu disease.
Harwood AR; Wojak JC; Barry R
J La State Med Soc; 2002; 154(3):154-5. PubMed ID: 12139363
[TBL] [Abstract][Full Text] [Related]
33. [Surgical treatment of epistaxis in Osler-Rendu-Weber disease].
Stastný B; Kroslák M
Cesk Otolaryngol; 1981 Jan; 30(1):53-6. PubMed ID: 7214573
[No Abstract] [Full Text] [Related]
34. Worsening of nose bleeding heralds high cardiac output state in hereditary hemorrhagic telangiectasia.
Khalid SK; Pershbacher J; Makan M; Barzilai B; Goodenberger D
Am J Med; 2009 Aug; 122(8):779.e1-9. PubMed ID: 19635281
[TBL] [Abstract][Full Text] [Related]
35. Progressive laser treatment of hereditary hemorrhagic telangiectasia of the gingiva: case report.
Finkbeiner RL
Int J Periodontics Restorative Dent; 2004 Jun; 24(3):288-94. PubMed ID: 15227777
[TBL] [Abstract][Full Text] [Related]
36. [Endoscopic intranasal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia].
He MQ; Liu YQ; Xu T
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 43(9):703-4. PubMed ID: 19035267
[No Abstract] [Full Text] [Related]
37. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.
Folz BJ; Wollstein AC; Lippert BM; Werner JA
Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077
[TBL] [Abstract][Full Text] [Related]
38. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
Luk L; Mace JC; Bhandarkar ND; Sautter NB
Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
[TBL] [Abstract][Full Text] [Related]
39. Surgical management of life-threatening epistaxis in Osler-Weber-Rendu disease.
Rebeiz EE; Bryan DJ; Ehrlichman RJ; Shapshay SM
Ann Plast Surg; 1995 Aug; 35(2):208-13. PubMed ID: 7486747
[TBL] [Abstract][Full Text] [Related]
40. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia.
Lennox PA; Harries M; Lund VJ; Howard DJ
J Laryngol Otol; 1997 Jan; 111(1):34-7. PubMed ID: 9292128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
